These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4019453)

  • 1. Analysis of ligand binding to receptors by competition kinetics. Application to muscarinic antagonists in rat brain cortex.
    Schreiber G; Henis YI; Sokolovsky M
    J Biol Chem; 1985 Jul; 260(15):8789-94. PubMed ID: 4019453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic antagonists induce different receptor conformations in rat adenohypophysis.
    Henis YI; Sokolovsky M
    Mol Pharmacol; 1983 Nov; 24(3):357-65. PubMed ID: 6633502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate constants of agonist binding to muscarinic receptors in rat brain medulla. Evaluation by competition kinetics.
    Schreiber G; Henis YI; Sokolovsky M
    J Biol Chem; 1985 Jul; 260(15):8795-802. PubMed ID: 4019454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of competition kinetics to investigate rat brain muscarinic receptors.
    Schreiber G; Henis YI; Sokolovsky M
    Isr J Med Sci; 1987; 23(1-2):36-43. PubMed ID: 3570744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic antagonist binding to intact rat thymocytes.
    Maslinski W; Grabczewska E; Bartfai T; Ryzewski J
    Acta Chem Scand (Cph); 1990 Feb; 44(2):147-51. PubMed ID: 2206705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the association and dissociation rate constants of muscarinic antagonists on rat pancreas: rank order of potency varies with time.
    Waelbroeck M; Camus J; Christophe J
    Mol Pharmacol; 1989 Sep; 36(3):405-11. PubMed ID: 2779525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
    Delmendo RE; Michel AD; Whiting RL
    Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
    Rinner I; Porta S; Schauenstein K
    Endocrinol Exp; 1990 Mar; 24(1-2):125-32. PubMed ID: 2361455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
    Gao ZG; Liu CG
    Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
    Waelbroeck M; Gillard M; Robberecht P; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):91-9. PubMed ID: 3600616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioligand binding characteristics of the chicken cardiac muscarinic receptor.
    Michel AD; Whiting RL
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):279-84. PubMed ID: 2812039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptors.
    Waelbroeck M; Camus J; Winand J; Christophe J
    Life Sci; 1987 Nov; 41(19):2235-40. PubMed ID: 3118122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on muscarinic acetylcholine receptors from mouse brain: characterization of the interaction with antagonists.
    Kloog Y; Sokolovsky M
    Brain Res; 1978 Apr; 144(1):31-48. PubMed ID: 638762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anomalous binding of [3H]N-methylscopolamine to rat brain muscarinic receptors.
    Lee JH; el-Fakahany EE
    Eur J Pharmacol; 1985 Apr; 110(2):263-6. PubMed ID: 3987816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes.
    Liebmann C; Nawrath S; Schnittler M; Schubert H; Jakobs KH
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):7-15. PubMed ID: 1538792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
    Christopoulos A; Mitchelson F
    Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.